ABSTRACT The steps involved during the biofilm growth cycle include attachment to a substrate followed by more permanent adherence of the microorganisms, microcolony arrangement, and cell detachment required for the dissemination of single or clustered cells to other organ systems. Various methods have been developed for biofilm detection and quantitation. Biofilm-producing microorganisms can be detected in tissue culture plates, using silicone tubes and staining methods, and by visual assessment using scanning electron microscopy or confocal scanning laser microscopy. Quantitative measurement of biofilm growth is determined by using methods that include dry cell weight assays, colony-forming-unit counting, DNA quantification, or XTT 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide reduction assay. Upon infection, innate immune defense strategies are able to establish an immediate response through effector mechanisms mediated by immune cells, receptors, and several humoral factors. We present an overview of the life cycle of biofilms and their diversity, detection methods for biofilm development, and host immune responses to pathogens. We then focus on current concepts in bacterial and fungal biofilm immune evasion mechanisms. This appears to be of particular importance because the use of host immune responses may represent a novel therapeutic approach against biofilms.
INTRODUCTION
Historically, microbial organisms have been grown in pure liquid cultures as free-floating "planktonic" cells, promoting the general theory of the unicellular lifestyle. However, in the late 1970s, Costerton et al. (1) demonstrated that groups of bacteria were embedded in a highly hydrated polysaccharide matrix that mediated adhesion to solid aquatic surfaces. Several years later, the same research team called these cellular communities "biofilms," defined as a functionally heterogeneous aggregate of microcolonies or single cells encased in a matrix of self-produced extracellular polymeric molecules that could adhere either to organic, abiotic surfaces or to each other (2) . Microbial biofilms can develop into highly organized structures containing channels in which water, nutrients, and metabolic waste can be transported. Adhesion to substrates or surfaces induces expression of a large number of genes, while cell aggregates in different regions in a biofilm exhibit different gene expression profiles that regulate biofilm development and maturation processes (3, 4) . A large amount of research since the 1980s has brought to light the theory that most, if not all, bacteria and fungi can form biofilms as a survival mechanism in hostile environments, providing protection from biotic and abiotic stresses (5) (6) (7) (8) . Prime candidates for cell attachment and biofilm growth are surfaces exposed to or containing moisture and some nutrients. Natural or man-made substrates for cell attachment and biofilm growth include river stones, oil and gas installations, ship hulls, water pipes, food-processing surfaces, contaminated surgical instruments, indwelling medical devices, human teeth, and infected wounds (9) (10) (11) . In this chapter, we will present an overview of the life cycle of biofilms and their diversity, detection methods for biofilm development, and host immune responses to pathogens. We will then focus on current concepts in bacterial and fungal biofilm immune evasion mechanisms.
BIOFILM FORMATION
Although different model systems have been described to define biofilm development in bacteria and fungi, the steps involved in the biofilm growth cycle are fairly universal with many common characteristics ( Table 1 ). In the human body, attachment to accessible human host proteins is the first step of biofilm formation and is dependent either on the hydrophobic nature of microbial surfaces or on specific cell surface molecules that enable adherence to host proteins. For example, Staphylococcus epidermidis and Staphylococcus aureus express MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) that have domains for noncovalent attachment to peptidoglycan moieties and also harbor binding sites for fibronectin, fibrinogen, laminin, collagen IV, and other human matrix proteins (12, 13) . For bacteria with flagellar motility, swimming cells attach to the surface first transiently and then permanently, expressing conditionally synthesized adhesive proteins to form a monolayer biofilm (14, 15) . Like the exopolysaccharide (EPS) matrix of bacterial biofilms, the polysaccharide capsule of Cryptococcus neoformans, a human pathogenic fungus, promotes the attachment process to prosthetic medical devices, whereas cell-surface glycoproteins facilitate adhesion of Candida albicans and Candida glabrata (16) (17) (18) (19) . Attachment is promoted by several environmental signals, such as changes in nutrient concentrations, pH, flow velocity of surrounding body fluids (urine, blood, saliva), temperature, oxygen concentration, osmolality, and iron.
The next phase of biofilm formation is characterized by a microcolony arrangement on the attached surface produced by the multiplication of free-floating cells; motility is reduced and exopolysaccharide production is activated to trap nutrients and planktonic cells, whereas signal molecules are secreted in a cell-density-dependent manner to communicate and coordinate the cellular responses through a process called quorum sensing. The presence of farnesol, a quorum sensing molecule first described in C. albicans, has been found to inhibit the yeast-to-mycelium conversion, enhancing active budding yeast production without compromising cellular growth rates (20) . In Pseudomonas aeruginosa, rhamnolipids maintain biofilm architecture by affecting the attachment of bacterial cells to substrates and cell-tocell-interactions. When cell density increases during the later stages of the maturation phase, rhamnolipids maintain open channels between cellular aggregates to distribute certain types and amounts of nutrients to support cell growth (21) .
Another way to trap both nutrients and planktonic cells once a critical biofilm mass has been achieved is the production and secretion of extracellular matrix predominantly composed of polysaccharides, proteins, and extracellular DNA (eDNA). This matrix promotes initial cell adhesion, triggers polysaccharide formation, and serves as a support that links molecules together in the biofilm matrix, thus influencing the structure and organization of mature biofilms. Extracellular DNA is an important component of Aspergillus fumigatus biofilms that originates from either fungal autolysis (22) or is externally supplied from human neutrophils attracted to the infected site (23, 24) .
The last phase of biofilm formation is cell detachment, which is required for the dissemination of single or clustered cells to other organ systems. Factors that could contribute to cell dispersal include sheer mechanical forces (blood flow), enzymes that digest the extracellular matrix, and nutrient limitation in a mature biofilm. The dispersed cell population of C. albicans displays yeast morphology with different phenotypic characteristics from their planktonic counterparts, including increased adherence capacity, filamentation, biofilm formation, and increased pathogenicity to establish new foci of infection (25) . In staphylococci, quorum sensing-controlled phenol-soluble modulins (PSMs) participate in establishing biofilm architecture as well as detachment processes using a mechanism similar to that used by P. aeruginosa but with different effector molecules. PSMs are part of a novel toxin family with multiple roles in staphylococcal pathogenesis, because they promote formation of biofilm During the dispersal phase, PSMs act as surfactantlike peptides that inhibit cell-to-cell interactions at the surface of the biofilm, leading to the detachment of bacterial cells at the fluid-biofilm interphase and the subsequent systemic spread of biofilm-associated infections (26, 27) .
Natural biofilms in most environments, including human disease, tend to coexist forming polymicrobial communities (28, 29) . The interactions that take place between fungal and/or bacterial species can either be synergistic or antagonistic in nature (30) . An example of a mutually beneficial interaction is a phenomenon called "coaggregation symbiosis" that is observed between C. albicans and S. aureus, whereby Candida hyphal penetration through epithelial layers provides a route of entry for staphylococci. Moreover, the observed hyphal-mediated increased pathogenicity of S. aureus may be attributed not only to the physical interactions but also to the differential regulation of virulence factors produced during polymicrobial growth (31) . Different microbial species in a single biofilm community could offer passive resistance, metabolic cooperation, quorum sensing systems, and genotypic variability that give an advantage to counteract adverse environmental conditions (32) . In contrast, the interactions between A. fumigatus and P. aeruginosa (both present in the cystic fibrosis [CF] lung microbiome) is described as being antagonistic. A. fumigatus biofilm formation is inhibited by direct contact with a P. aeruginosa-secreted heat-stable soluble factor, suggesting that small diffusible molecules can interfere with filamentous fungal growth in polymicrobial environments (33) . Although in recent years investigations have shifted to polymicrobial biofilms, there is considerable knowledge yet to be gained in our understanding of microbial cohabitation and microbes' interaction with the host to control the impact of polymicrobial biofilm-associated diseases.
DETECTION AND QUANTIFICATION METHODS OF BIOFILM FORMATION
Various methods have been developed for biofilm detection and quantitation (Table 2) . They include staining and microscopic visualization of biofilm structure as well as quantitation of the numbers of biofilm-associated cells in situ or after detachment of microbial cells from the substrate. Biofilm-producing microorganisms are also detected by methods that include growth in tissue culture wells or silicone tube biofilm reactors, followed by staining with Congo red or crystal violet stains. These stained biofilms can be visually assessed by scanning electron microscopy or confocal scanning laser microscopy, which is most effective for studying an intact biofilm's three-dimensional architecture (34) (35) (36) . Quantitative measurement of biofilm growth is determined by using methods that include determining dry cell weight assays, assessing colony forming unit by plating on solid media, DNA quantification, or an XTT 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide reduction assay (34, 37, 38) . The latter method is colorimetric and uses XTT, a colorless or slightly yellow compound that when reduced to a formazan product becomes bright orange. The oxidation-reduction process is initiated by mitochondrial dehydrogenases of metabolically active cells. The colorimetric change is proportional to the number of living cells and can be quantified spectrophotometrically. The biodiversity and abundance of biofilm-associated microorganisms in polymicrobial communities is detected using a combination of molecular diagnostics based on PCR, sequencing technologies, and advanced mathematical algorithms to identify the biofilm-producing microorganisms present and to analyze the copy number of each organism relative to the total number of copies for all organisms (39) (40) (41) .
HOST DEFENSES AGAINST BIOFILMS
Upon infection, innate immune defense strategies are able to establish an immediate response through effector mechanisms mediated by immune cells, receptors, and several humoral factors ( Table 3 ). The main role of humoral factors, such as mannose binding lectins, collectins, complement, and antibodies, is to bind invading microbes and promote receptor-mediated recognition and phagocytosis by cells of the innate immune system. Pathogen-associated molecular structures found on the surface of microbes are recognized by XTT reduction assay Visual assessment by scanning electron microscopy Visual assessment by confocal scanning laser microscopy specific receptors on natural killer cells or professional phagocytes consisting of polymorphonuclear neutrophils (PMNs), mononuclear leukocytes (macrophages), and dendritic cells (DCs). Toll-like receptors (TLRs), the best-defined immune sensors of invading pathogens on the surface of phagocytes, initiate a cascade of signaling pathways that induce phagocytosis, secretion of antimicrobial products generated in phagocytes by oxidative and nonoxidative mechanisms, release of proand anti-inflammatory cytokines, or other factors that contribute to the activation, maturation, and immunoregulation of adaptive immune responses. DCs are the main cell populations that bridge innate and adaptive immunity, because recruitment by inflammatory signals leads to DC accumulation at injured or infected sites to capture, internalize, and present microbial cell fragments to naïve T cells in the lymph nodes. TLRs and C-type lectin receptors contribute to the recognition and activation of specific DC programs to decode the structural information of the antigens captured and to convert it into different T-cell immune responses (42) (43) (44) (45) . Thus, early phases of immune response help to control excessive propagation of pathogens, while activation of proper T cell subsets leads to long-lived protective immunity.
In most of the studies conducted to date, hostpathogen interactions concern bacteria and fungi in their free-living planktonic state. However, despite the paucity of information, recent studies have begun to investigate immune responses to biofilms. Antimicrobial factors, such as lactoferrin and the human cationic host defense peptide LL-37 found at mucosal surfaces or in secondary granules of PMN, when used in vitro at very low concentrations, strongly inhibit formation of P. aeruginosa biofilms. Lactoferrin, as an iron-binding glycoprotein, reduces the iron supply necessary for biofilm growth and promotes twitching motility (46) , whereas LL-37 reduces the initial attachment phase, increases surface motility, and interferes with the quorum sensing system of P. aeruginosa (47). However, bacteria are known to counteract such host defense processes by secreting proteases able to degrade both lactoferrin and LL-37 (48, 49) . Although specific immune receptors for the biofilm mode of growth have not been identified, the active involvement of PMNs against biofilms is demonstrated by the increased oxygen depletion caused by enhanced oxidative burst, by the increased glucose uptake by PMN in CF lungs, and by the high concentration of L-lactate in the sputum of CF patients with chronic lung infection (50) . It has been shown that upon contact of PMNs with S. aureus biofilms, a decrease in biofilm mass is caused by phagocytosis, rapid degranulation of lactoferrin and elastase, and finally, DNA release (51). Time-lapse video microscopy has documented migration of PMNs into S. aureus biofilms, and clearance of bacterial cells within the biofilm by phagocytosis is shown to be dependent on biofilm maturation, because young biofilms are more susceptible to PMN antimicrobial functions compared to mature biofilms (52) . In contrast to planktonic cells of S. epidermidis, adherence of PMNs to biofilms and phagocytosis seems to be opsonization-independent, suggesting that biofilms could contain PMN signaling molecules (53) . Confocal scanning laser microscopy shows that phagocytes enhance the ability of C. albicans to form biofilms and that these phagocytes appear as unstimulated rounded cells, inducing significantly less damage to biofilms than their planktonic counterparts (54, 55) . C. neoformans, an encapsulated fungus that can cause meningoencephalitis in immunocompromised patients, shows resistance to oxidative stress, but it becomes considerably more susceptible to cationic antimicrobial peptides when switching to the biofilm mode of growth. Defensins with higher net positive charges (β-defensin-1, β-defensin-3) interact strongly with negatively charged biofilm surfaces, while their hydrophobic characteristics enable them to enter the cells' membranes and create temporary pores through which cell contents leak, leading to cell death. In contrast, defensins with lower net positive charges (α-defensin-3 and magainin-1) are less efficient against biofilms, implying that the greater affinity to biofilms results in increased biofilm susceptibility (56) .
C. neoformans capsule is primarily composed of glucuronoxylomannan, a polysaccharide present in large amounts in the extracellular biofilm matrix and for this reason indispensible for biofilm formation. Moreover, it has been shown that anti-C. neoformans antibodies have a multitude of protective functions, including enhancement of animal survival against cryptococcosis, promotion of phagocytosis, antigen presentation, complement activation, and modulation of immune protein expression. Testing the hypothesis that antibodies could also interfere with biofilm production, Martinez and Casadevall demonstrated that monoclonal antibodies raised against glucuronoxylomannan inhibit biofilm formation, suggesting that humoral immune responses could be important to the prevention of biofilm formation. In the clinical setting, administration of protective antibodies could present a valuable alternative in the management of biofilm-associated diseases (17) .
HOW BIOFILMS OF BACTERIA AND FUNGI EVADE HOST DEFENSES Staphylococcus spp.
Staphylococcus spp. are among the leading causes of health care facility-and community-associated infections. S. epidermidis and S. aureus are frequent etiologic factors of biofilm-associated infections on indwelling medical devices as well as chronic and recalcitrant infections such as endocarditis, periodontitis, rhinosinusitis, and osteomyelitis (57) . The emergence of drug-resistant strains, especially methicillin-resistant S. aureus, further accentuates their therapeutic difficulty. While the bulk of the available information on biofilms concerns biofilm development, the host immune responses against biofilm infections remain largely unidentified.
Initial studies of medically relevant S. aureus biofilms showed that human leukocytes are able to effectively penetrate the biofilm, possibly by using the nutrient channels that exist in mature biofilms; however, leukocytes exhibit impaired phagocytosis and show a decreased ability to kill the bacteria (58) . Subsequent studies using more sophisticated methods demonstrated that PMNs are able to clear Staphylococcus spp. biofilms by phagocytosis (51, 52, 59) . Furthermore, immature biofilms were more sensitive to phagocytosis compared to mature ones, although mature biofilms are not entirely immune to PMN attack (52) . By comparison, macrophages did not show appreciable phagocytosis of S. aureus biofilms. Of note, macrophages were capable of engulfing disrupted biofilm material, suggesting that the size and/or physical complexity of biofilm ultrastructure are responsible for their recalcitrance to phagocytosis (60) .
The opsonization of S. aureus biofilms with immunoglobulin G did not affect the adherence of PMNs to the biofilms; however, it increased the clearance of biofilm, possibly through upregulated oxygen radical production in PMNs (61) . It seems that biofilm matrix can protect bacteria from antibody-mediated phagocytosis (62) .
Another mechanism utilized by S. aureus biofilms to evade host immunity, which may explain their in vivo persistence, is the macrophage dysfunction and cell death caused upon contact with the biofilm itself. It was noted that macrophages showed a differential sensitivity to cell death based on their physical distance from the biofilm surface, with macrophages most intimately associated with biofilm being dead, while macrophages that remained above the biofilm surface remained viable (60) . Among the potential mechanisms proposed to account for this phenomenon is the phenomenon of metabolic "layering" within the biofilm (63) . Regions of anaerobic and aerobic microenvironments within the biofilm, bacterial-influenced fluctuations in pH, and macrophage survival may be affected due to the release of bacterially produced toxic byproducts of metabolism. Furthermore, the biofilm may contain lytic toxins, which may lead to cell death.
Using a mouse model of catheter-associated biofilm infection, it was demonstrated that several inflammatory signals responsible for macrophage and neutrophil
ASMscience.org/MicrobiolSpectrumrecruitment (CCL2 and CXXL2, respectively) and activation (tumor necrosis factor alpha and interleukin [IL]-1β) were significantly reduced in biofilm-infected tissues compared to the wound healing response elicited by sterile catheters (60) . The role of IL-1β is potentially mediated through the MyD88-dependent pathway and can reduce biofilm development but is not sufficient to eradicate staphylococcal biofilms (63) . Additionally, inducible nitric oxide synthase (iNOS) expression was decreased and arginase-1, a key enzyme involved in collagen biosynthesis, was increased in macrophages surrounding the biofilm. These findings would be expected to skew the cellular response away from bacterial killing to favor fibrosis and could represent another mechanism to account for the ability of biofilms to evade clearance (60, 63) . Further in vivo data showed that S. aureus biofilms could evade TLR2 and TLR9 recognition (60) . While the mechanism responsible for TLR2/ TLR9 evasion is not known, it could be attributed to ligand inaccessibility.
Current data collectively indicate that the persistence of staphylococcal biofilm could be attributed to its ability to skew the immune response to favor anti-inflammatory and pro-fibrotic pathways. As such, it has been shown that targeting macrophage proinflammatory activity can represent a novel therapeutic strategy to overcome the local immune inhibitory environment created during biofilm infections (64) .
From the currently available data, one can deduce that innate host defense cells may be able to recognize Staphylococcus spp. biofilms, migrate toward biofilms, and degrade biofilms in vitro. However, the latter depends greatly on the experimental conditions, namely the Staphylococcus strain, biofilm maturation phase, opsonization with immunoglobulin, and the immune cell population used. It is likely that the unique properties of Staphylococcus spp. biofilms circumvent traditional antimicrobial pathways. Additional studies are warranted to investigate the mechanisms that lead to host defense impairment upon contact with Staphylococcus spp. biofilms.
Pseudomonas spp.
The opportunistic pathogen P. aeruginosa has drawn special attention in the biofilm field due to its role in chronic and recalcitrant infections, particularly lung infection of CF patients, ventilator-associated pneumonia, chronic wounds, otitis media, and medical devicerelated infections. In humans, infection by P. aeruginosa, and subsequent biofilm formation, invariably occurs in association with an exuberant inflammatory response.
Pseudomonas biofilm-related infections seem to follow the current dogma regarding host defense mechanisms where immune responses fail in eradicating biofilms (65) .
Initial studies using a chemiluminescence assay showed that while biofilms of P. aeruginosa were capable of activating the oxidative burst response of PMNs, this response was reduced by about 25% compared to planktonic cells (66) . In vitro microscopic evidence suggests that the normal migratory behavior of phagocytes is disrupted by P. aeruginosa biofilms. The innate cells settle into biofilms but do not appear to be capable of migrating from the point of contact even though they appear to mount a respiratory burst, degranulate, and retain their phagocytic and secretory activity. The mechanism by which the biofilms immobilize neutrophils (yet they are still capable of phagocytosing bacteria) is not known (67) . It is possible that exotoxins or other components produced by P. aeruginosa and immune cells, respectively, may play a role (46, 67) . Others suggest that P. aeruginosa biofilm tolerance to PMNs is quorum sensing dependent (68) .
It has also been reported that P. aeruginosa biofilm formation is increased by 2-to 3.5-fold in the presence of PMNs (69, 70) . The mechanism of biofilm enhancement by PMNs was attributed to PMN-generated polymers comprised of actin and DNA (69) . This is consistent with the clinical finding of higher numbers of necrotic PMNs detected in CF lungs infected with P. aeruginosa compared with other bacterial infections (71) . Lactoferrin, a common secretory component of human neutrophil granules, has been shown to inhibit P. aeruginosa biofilm production (46). However, lactoferrin inhibitory effect was not evident when the total content of neutrophil granules was combined with P. aeruginosa (69) . In this regard, it is likely that the role of lactoferrin in microbial biofilms is modulated by scavenging and protease-or oxygen radical-mediated degradation by P. aeruginosa and neutrophils (46, 67) .
The pathogen-beneficial effects of the biofilm matrix have been demonstrated in other studies (65, 72) . The exopolysaccharide alginate protects P. aeruginosa biofilm bacteria from leukocyte phagocytosis. In vitro studies demonstrate that in the presence of the potent leukocyte activator interferon-γ, human phagocytes killed P. aeruginosa biofilm bacteria lacking the ability to produce the alginate exopolysaccharide (72) . Of note, the inability of innate cells to eliminate biofilms is abolished as soon as biofilm cells are mechanically disrupted into individual cells (65, 73) .
There is increasing evidence supporting the role of rhamnolipids (a class of glycolipids produced by P. aeruginosa that are considered a key virulence determinant acting under the control of the quorum sensing system) in the host defense against PMNs, especially in CF lung infection or other chronic infections (65, 74) . The activity of rhamnolipids was shown in vitro and in vivo in pulmonary models, where P. aeruginosa biofilms produce a shield of excreted rhamnolipids that protects from the bactericidal activity of PMNs (65, 75, 76) . Accordingly, disabling the biofilm shield of rhamnolipids either by mutation or by treatment with quorum sensing inhibitors leads to increased PMNmediated clearance of the biofilm (65, 76) . Rhamnolipids appear to be a crucial component of a vicious self-enhancing cycle in which rhamnolipids induce necrotic lysis of PMNs, and the lysed PMNs subsequently cause more inflammation and in turn attract more PMNs (65) . The hypothesis of a "biofilm shield" of rhamnolipids which offers protection from the antibacterial activity of PMNs seems to contribute to biofilm infections of P. aeruginosa (65).
Candida spp.
While the interactions between the host immune system and planktonic Candida cells have been extensively examined, the corresponding biofilm interactions are largely unstudied (77) . Initial studies showed that monocytes influence the ability of C. albicans to form biofilms. Monocytes exert a biofilm-enhancing effect, which has been associated with a modulated immune response of increased levels of pro-inflammatory cytokines such as IL-1β and decreased levels of IL-6, IL-10, MCP-1, I-309, and tumor necrosis factor alpha (54) . Overall, Candida biofilms appear to have an immunosuppressive effect, because monocytes are unable to phagocytose fungal cells in the maturing biofilms and appear to be entrapped within the biofilm ultrastructure (54) . Lack of monocyte-mediated phagocytosis within biofilms was also observed for different stages of C. albicans biofilm development. Confocal scanning microscopy showed that human phagocytes resemble unstimulated cells, presenting a rounded shape when in the presence of biofilms (55) . This was also confirmed by reduced cytokine production in the biofilm-phagocyte co-culture compared to a planktonic cell-phagocyte mixture (55) . However, the same phenomenon was not observed with dislodged biofilm cells (55) . Consistently, mature Candida biofilms were more resistant to killing by leukocytes than early biofilms. Further, mature biofilms failed to trigger a reactive oxygen species response (78) . The architecture of mature biofilms and the presence of β-glucans in the extracellular matrix represent an important innate immune evasion mechanism of C. albicans biofilms (55, 78) .
Previous studies have unequivocally shown that interferon-γ and granulocyte colony-stimulating factor enhance the antifungal activity of human PMNs against planktonic Candida spp. (77) . On the contrary, exposure of C. albicans biofilms to cytokine-activated PMNs does not enhance biofilm damage (77, 79) . The increased biofilm damage induced by cytokine-activated PMNs can be explained by the upregulatory activity of the two cytokines to the number and/or to the affinity of the mannose and FcγR receptors on the surface of the phagocytes leading to a more efficient interaction between PMNs and fungal targets. Knowing that killing of C. albicans requires ligation of the various host immune receptors by C. albicans surface structures (mannoproteins, mannans, or β-glucans) and knowing the role of extracellular matrix to biofilm immune evasion, the lack of cytokine effectiveness was attributed to the inability of the effector cells to recognize the cells within the biofilm (79) . Nevertheless, the notion of biofilm recognition by the immune system appears to be important. Large amounts of (1→3)-β-D-glucans are found in the extracellular matrix of Candida biofilms in vitro and in vivo (80) (81) (82) . In addition, Hyr1, which encodes cell surface glycosyl phosphatidylinositolanchored proteins, confers resistance to neutrophil killing in vitro and in an oral mucosal tissue biofilm model (81, 83) .
In this regard, exposure of C. albicans biofilms to anidulafungin, an antifungal agent that causes heightened β-glucan exposure, was associated with a significant increase in phagocyte-mediated damage and a larger pro-inflammatory response from phagocytes (55) . Furthermore, Candida spp. biofilms were more susceptible to the combined effect of anidulafungin with phagocytes compared to voriconazole with phagocytes (55, 79) . These data underline the notion that echinocandins (i.e., caspofungin, micafungin, and anidulafungin) have immunomodulatory effects on host cells against biofilms.
Other Organisms
Enterococci constitute an important cause of hospitalacquired infections and become particularly pathogenic in intensive care settings, in debilitated patients with impaired immune systems, and in the elderly. Despite the clinical importance of enterococci, little is known about their interactions with immune cells (84, 85) . The prevailing notion that biofilm cells encased in an
ASMscience.org/MicrobiolSpectrumexopolysaccharide matrix are resistant to phagocytosis by immune cells seems to contradict recent findings (86, 87) . In vitro studies showed that immune cells are able to phagocytose enterococcal cells recovered from biofilms as effectively as their planktonic counterparts (86, 87) . In addition, enterococcal biofilms seem to elicit a differential immune response relative to planktonic cells, in that infected monocytes with enterococcal biofilm cells invoke less pro-inflammatory cytokine and chemokine expression (86, 87) . However, in vivo it is likely that the complex involvement of multiple host factors may allow biofilm cells to circumvent host defenses, thus explaining the persistence of biofilm-related infections.
Aspergillus spp. are frequently isolated from the respiratory tract of patients with CF (88) , where it causes typical biofilms and may be associated with deterioration of lung function, invasive infection, or allergic bronchopulmonary aspergillosis. Host defenses against Aspergillus in the respiratory tract of CF patients have been reviewed (89, 90) . Like all biofilms, Aspergillus biofilms are quite resistant to the antifungal activity of PMNs and macrophages, the two major airway phagocytes. Of note, Aspergillus downregulates vitamin D receptor gene and protein expression in vitro and in vivo. This is mediated by the fungal virulence factor gliotoxin, an immune-evader and promoter of cellular apoptosis. Reduced gliotoxin and IL-5 as well as IL-13 (Th2 cytokines) concentrations were detectable postitraconazole treatment in patients with CF and Aspergillus with concomitant increases in vitamin D airway receptor expression (91) .
HIGHLIGHTS OF RECENT FINDINGS AND FUTURE QUESTIONS
A large range of biofilm model systems has been developed; however, the technical challenges associated with the growth and assessment of biofilm development further complicate the generalization of the results of various studies. In assessing the effects of host defenses on microbial biofilms, the experimental conditions, the thickness, and the complexity of biofilms should be considered. A major challenge in biofilm research is the development of suitable models that effectively reproduce the host defense conditions at different infection sites and that permit evaluation of the efficacy of novel antifungal treatment strategies under in vivo conditions (92) . Animal models of biofilm formation represent an invaluable alternative for improving our understanding of biofilm development inside the host, their resilience to immune cells, and their interaction with the host immune defense system. This appears to be of particular importance because the use of host immune responses may represent a novel therapeutic approach against biofilms (64) .
